Search is Powered by Google
Follow us on:
Follow our health news on Twitter
Follow Our News on Facebook
Personalization
login | register
Women's Health / Gynecology News

New model of aspirin therapy in preeclampsia

Main Category: Women's Health / Gynecology
Article Date: 18 Mar 2005 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions


Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

Preeclampsia is a hypertensive disorder that occurs during pregnancy and can be detrimental to the health of the developing fetus and the mother. Low-dose aspirin therapy has been used to treat preeclampsia, but this strategy is controversial - some researchers believe that it prevents preeclampsia while others find it increases related complications.

In a study appearing online on March 17, in advance of the April 1 print edition of the Journal of Clinical Investigation, Colin Funk and colleagues from the University of Pennsylvania describe a new mouse model that mimics the effects of low dose aspirin to explore how such therapy would impact blood clotting and reproductive functions.

The mice generated have reduced levels of prostaglandin H synthase 1 (PGHS1), a platelet protein that contributes to the heart-healthy effects of aspirin therapy. The authors find that these mice had the expected decreased platelet aggregation, inhibition of thrombosis, and impaired inflammatory responses typically seen with aspirin therapy. However, the uterine and ovarian environments were altered only slightly and allowed for normal induction of labor, normal litter size and similar development of offspring.

This new mouse model will have significant value in studying the role of low dose aspirin in several pathological conditions, such as preeclampsia, thrombosis and inflammation. The results suggest that low-dose aspirin treatment may prevent preeclampsia without compromising reproductive function.

TITLE: Differential impact of prostaglandin H synthase 1 knockdown on platelets and parturition

View the PDF of this article at: the-jci.org/press/23683.pdf
From 5:00PM USA EST Thursday March 17, 2005 a PDF of this article will be available at: jci.org/papbyrecent.shtml

Contact: Stacie Bloom
press_releases@the-jci.org
212 342 4159
Journal of Clinical Investigation
jci.org




Personalized Homepage Weekly Newsletters Daily News Alerts
Hemophilia Opioid Induced Constipation Pneumococcal Disease ADHD Anxiety Asthma Atrial Fibrillation Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Forum Icon

Women's Health Forum

Discuss issues relating to women's health / gynecology in our new forum.

Visit the women's health forum


These are the most read articles from this news category for the last 6 months:
Top Article Star
Criticism Of Popular Oral Contraceptive Yaz Could Harm Product's Appeal, New York Times Reports
29 Sep 2009
The popular oral contraceptives Yaz and Yasmin have been tainted recently by safety concerns raised by researchers, health advocates and lawyers for plaintiffs who have filed lawsuits against manufacturer Bayer Healthcare, the New York Times reports...


Treating Postpartum Depression image Treating Postpartum Depression

Postpartum depression affects anywhere from 10 to 20 percent of new moms. Thankfully, postpartum depression is an extremely treatable illness...

Talking with Your Doctor image Talking with Your Doctor

Talking with your doctor can sometimes be difficult. Good health care, however, depends on an open dialogue between patients and doctors...

View more videos...